News|Videos|October 22, 2025

Ashland Previews Fall Conference Exhibits, Including Expanded High-Purity Sugar Portfolio: Video Summary

At CPHI and AAPS, Ashland plans to detail the impacts of its advanced excipients: ultra-low nitrite materials curb nitrosamine risk, while high-purity sucrose stabilizes complex biologics.

Ashland is enhancing its pharmaceutical ingredients portfolio, focusing on high-purity excipients for injectables and low-nitrite offerings for oral solid doses, according to an announcement detailing products to be featured at CPHI Frankfurt, from Oct. 28–30, 2025, and AAPS PharmSci 360, to be held in San Antonio, Texas from Nov. 9 to 12, 2025 (1).

Related to this article

November 12th, 2026

Investing in Protecting Pharma Products

Terry Katz, CEO and co-founder of ForgeStop Technology Corporation, explains how the company’s product is worth the investment by protecting products and patients.

November 11th, 2026

Choosing a Connected Product Technology for Anticounterfeiting

Terry Katz, CEO and co-founder of ForgeStop Technology Corporation, explains how its connected technology can enhance anticounterfeiting and how data are handled within the product.

November 11th, 2026

Green Chemistry Supply and Demand in Sustainable Pharma

Celtic Renewables won the CPHI Award for Sustainable Pharma Excellence for its green chemicals used in pharmaceutical manufacturing. Bettina Brierley, chief commercial officer, talks about the adoption, capacity, and pricing of biosolvents.

November 11th, 2026

CPHI Pharma Award Winner: Drug Delivery, Devices, & Packaging

Terry Katz, CEO and cofounder of ForgeStop Technology Corporation, explains the company’s CPHI Award-winning connected product technology and how it helps to combat drug counterfeiting.

November 11th, 2026

CPHI Award for Sustainable Pharma Excellence: Green Chemicals

Bettina Brierley, chief commercial officer at Celtic Renewables, discusses commercialization of biosolvents for pharmaceutical manufacturing.

November 5th, 2026

Supply Chain Excellence Through Just-in-Time Manufacturing

Almac Clinical Services’ clinical supply strategy won the 2026 CPHI Award for Supply Chain Excellence. Nishma Patel, supply chain solutions manager, explains the benefits and challenges of the company’s just-in-time manufacturing solution.

November 9th, 2026

The Impact of Excipients on Continuous Manufacturing and the Risk of Nitrites

CPHI Award winner, Pauline van der Wijst-Janssen, PhD, product development manager and global technical lead at DFE Pharma, explains excipient variability and excipients’ role in continuous manufacturing.

November 9th, 2026

CPHI Milan Future Leader Award Winner: Pauline van der Wijst-Janssen

Pauline van der Wijst-Janssen, PhD, of DFE Pharma, won the CPHI Pharma Award for Future Leader. In this interview with PharmTech, she provides advice for scientists looking to advance to leadership roles.